Capable of restoring skin health and beauty without compromising safety, Unigen’s range of high-quality botanical solutions are obtained through Unigen’s proprietary Phytologix® Platform. The PhytoLogix® platform is a combination of nature, science, traditional medicinal botanicals, and dermatological screening technology, allowing Unigen to deliver the highest quality to its customers.
Through this partnership six of Unigen Beauty’s ingredients have been added to the LEHVOSS Personal Care portfolio: Bakutrol®, an anti-acne solution; Soliprin™ for anti-aging, anti-oxidant, and protection against UV-induced stress; Uniflavon™, an anti-irritant; Preservatin™ an antimicrobial booster; Sveltrol™ for body firming; and Lumicyn™ for hyperpigmentation. Lumicyn™ is Unigen’s latest innovation that is launching at in-cosmetics and can be found in the Innovation Zone (115) and Sensory Bar.
“Unigen’s expertise and portfolio of high performing active ingredients are completely aligned with our focus on supporting our customers with safe, innovative, and sustainable solutions,” says Dr. Michael Lütke, Global Director of the LEHVOSS Personal Care Business. “The Unigen solutions address many of today’s main skin concerns such as such skin aging, skin sensitivity, and skin protection against UV exposure.”
”We are extremely excited to have developed the strategic partnership with LEHVOSS Personal Care and bring Unigen’s patented and clinically proven ingredients to the European market,” says Dr. Qi Jia, Unigen’s President and CEO. “Unigen and LEHVOSS will co-promote 6 bioactives at in-cosmetics Global, with ingredients featured at the Sensory Bar, Innovation Zone, Unigen’s booth K91 and LEHVOSS’ booth Z50.”
About Unigen, Inc.
Unigen discovers, develops, and manufactures proprietary natural-product active ingredients for dietary supplements, cosmetic and personal care products, prescription medical food and botanical drug products. The Company discovers its ingredients through its PhytoLogix® high-throughput screening approach applied to a proprietary well-annotated collection of botanicals and a legacy mining approach applied to botanicals having known medicinal benefits.
Mechanism of action, safety, and efficacy are documented with extensive preclinical in vitro and by human clinical studies. Unigen protects its discoveries with issued patents and patent filings in all major territories and manufactures its products to GMP standards. Unigen commercializes its proprietary ingredients through licensing and ingredient supply alliances with commercial partners engaged in the manufacture, distribution, and marketing of end-products in each of Unigen’s target markets.